The Importance of Dose Intensity When Administering Cytotoxic Chemotherapy in NSCLC—A Matter as Actual Now as in the Past
Nitipir, C.; Orlov-Slavu, C.; Olaru, M.; Parosanu, A.; Popa, A.-M.; Iaciu, C.; Popescu, B.C.; Barbu, M.A.; Pirlog, C.; Calu, V.; Popescu, A.C.; Bumbacea, D.; Paleru, C.; Slavu, I.; Alecu, L. The Importance of Dose Intensity When Administering Cytotoxic Chemotherapy in NSCLC—A Matter as Actual Now as in the Past. Processes 2020, 8, 936. https://doi.org/10.3390/pr8080936
Nitipir C, Orlov-Slavu C, Olaru M, Parosanu A, Popa A-M, Iaciu C, Popescu BC, Barbu MA, Pirlog C, Calu V, Popescu AC, Bumbacea D, Paleru C, Slavu I, Alecu L. The Importance of Dose Intensity When Administering Cytotoxic Chemotherapy in NSCLC—A Matter as Actual Now as in the Past. Processes. 2020; 8(8):936. https://doi.org/10.3390/pr8080936
Chicago/Turabian StyleNitipir, Cornelia; Orlov-Slavu, Cristina; Olaru, Mihaela; Parosanu, Andreea; Popa, Ana-Maria; Iaciu, Cristian; Popescu, Bogdan C.; Barbu, Maria A.; Pirlog, Cristina; Calu, Valentin; Popescu, Andreea C.; Bumbacea, Dragos; Paleru, Cristian; Slavu, Iulian; Alecu, Lucian. 2020. "The Importance of Dose Intensity When Administering Cytotoxic Chemotherapy in NSCLC—A Matter as Actual Now as in the Past" Processes 8, no. 8: 936. https://doi.org/10.3390/pr8080936